大动脉新皮化 (奥扎基手术) 的早期结果:单个中心的初始经验
Ranajit Naik1, Abhishek Prabhu1, Mohan Gan1
1Department of Cardiovascular & Thoracic Surgery, Jawaharlal Nehru Medical College, Belagavi, Karnataka, 590010, India.
Indian heart journal
|May 26, 2025
概括
大动脉新囊化 (AVNeo) 是对大动脉疾病的一种安全有效的程序,显示出出色的早期结果和低梯度. 这种技术提供了一种经济有效的替代方案,特别是在资源有限的地区.
科学领域:
- 心血管外科心血管外科
- 医疗器械 医疗器械
- 再生医学是一种再生医学.
背景情况:
- 大动脉的新皮化 (AVNeo),或奥扎基技术,在大动脉膜病变中使用自身心脏.
- 它比门更换提供了优越的血液动力学,并避免了终身抗凝.
研究的目的:
- 评估AVNeo手术在患有各种主动脉疾病的患者的早期结果.
- 在初步实验中评估AVNeo技术的可行性和可重复性.
主要方法:
- 一个回顾性队列研究,涉及2023年3月至2023年10月期间进行的17项AVNeo手术.
- 在基线,术后和一年后随访时进行心声图评估.
- 对并发症和死亡率的评估.
主要成果:
- 17名患者 (7-77岁) 接受了AVNeo治疗,以治疗狭窄或吐.
- 在手术后显著减少了平均和峰值大动脉梯度.
- 一年没有死亡率; 一名患者出现严重的大动脉反,需要重新干预.
结论:
- AVNeo是一种可行的和可重复的技术,具有有利的早期结果.
- 该程序表明低压梯度和轻度吐在一年后.
- AVNeo为大动脉膜病变提供了一种具有成本效益的解决方案,特别是在资源有限的环境中.
相关概念视频
Aortic Regurgitation I: Introduction
47
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
47
Mitral Stenosis I: Introduction
53
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
53
Aortic Regurgitation III: Medical Management
54
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
54
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
61
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
61
Mitral Valve Prolapse I: Introduction
52
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
52
Mitral Valve Prolapse II: Assessment and Management
49
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
49


